GENETICS OF RECURRENT EARLY ONSET DEPRESSION
复发性早发性抑郁症的遗传学
基本信息
- 批准号:6528536
- 负责人:
- 金额:$ 28.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-30 至 2003-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (Adapted from investigator's abstract) Major depressive disorder
(MDD) has at least a 5-10% lifetime population prevalence and causes severe
morbidity and mortality including suicide. Heritability in twins is 0.4-0.70.
Mapping of susceptibility genes may be feasible with the recurrent, early-onset
subtype (MDD-RE) which demonstrates a three- to eight-fold increase in risk to
first-degree relatives of probands, vs. twofold for all MDD. The complex
pattern of transmission suggests multigenic transmission and/or locus
heterogeneity, so that large samples may be required. We propose a four-year,
six-site project to collect an estimated 770 pedigrees which contain 1,000
independent affected sibling pairs (ASPs), extended by first-degree
relationships to include additional affected relatives, plus unaffected
relatives (parents and sibs) for genetic phase information. All sites will have
identical inclusion criteria, clinical assessment DIGS and FIGS interviews and
the NEO personality inventory), interviewer training and reliability
monitoring, consensus diagnostic procedures, data management system, and
administrative oversight including a quality assurance program. Permanent cell
line specimens will be created and DNA extracted at the NIMH-sponsored cell
repository. A 10 cM genome scan will be completed on all affected subjects at
the Center for Inherited Disease Research (CIDR), which has approved this
project for CIDR access. A three-stage design is proposed: regions with maximum
lod scores (MLS) exceeding a liberal simulation-based threshold will be
identified in a genome scan of the affected individuals from the first half of
the sample, and candidate regions selected which continue to meet this
threshold after unaffected individuals are typed in these regions and added to
the analysis. Evidence for linkage in these regions will then be tested in the
entire sample with parametric and non-parametric analyses using stringent
simulation-based thresholds for 5% genome-wide significance. In the four-year
project period, genetic analyses can be completed on 80% of the sample (over
600 pedigrees, 800 ASPs), with the remaining families to be available by the
end of the project period for immediate completion of the genome scan on these
pedigrees at CIDR.
A timetable is proposed for rapid sharing of all biological materials, blinded
clinical data, genotypes and linkage analyses with the scientific community
through the NIMH-sponsored Center for Genetic Studies.
描述:(改编自研究者摘要)重度抑郁症
(MDD)至少有5-10%的终生人口患病率,并造成严重的
发病率和死亡率,包括自杀。双胞胎的遗传度为0.4-0.70。
易感基因的定位可能是可行的复发性,早发性
亚型(MDD-RE),表现出三至八倍的风险增加,
先证者的一级亲属,而所有MDD的一级亲属为两级亲属。复杂
传播模式提示多基因传播和/或位点
不均匀性,因此可能需要大样本。我们提议一个四年期,
六个地点的项目将收集估计770个谱系,其中包含1,000个
独立受累同胞对(ASP),一级扩展
包括其他受影响的亲属,以及未受影响的亲属
亲属(父母和同胞)的遗传相位信息。所有研究中心都将
相同的入选标准,临床评估DIGS和FIGS访谈,
NEO人格调查表)、访谈者培训和可靠性
监测、共识诊断程序、数据管理系统,以及
包括质量保证计划在内的行政监督。永久细胞
将在NIMH赞助的细胞中创建细胞系标本并提取DNA
仓库。所有受影响的受试者将完成10 cM基因组扫描,
遗传疾病研究中心(CIDR)批准了这项研究。
项目CIDR访问。提出了三阶段设计:最大值区域
超过自由模拟阈值的lod分数(MLS)将被
在2009年上半年受影响个体的基因组扫描中发现,
所选择的样本和候选区域继续满足该
阈值后,未受影响的个人在这些地区分型,并添加到
的分析。这些地区的联系证据将在
整个样本的参数和非参数分析,使用严格的
5%全基因组显著性的基于模拟的阈值。技
在项目期间,可以对80%的样本(超过
600个家系,800个ASP),其余的家庭将由
在项目期结束后立即完成对这些人的基因组扫描,
在CIDR的家谱。
提出了快速共享所有生物材料的时间表,
临床数据、基因型和与科学界的关联分析
通过NIMH赞助的遗传研究中心。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM A SCHEFTNER其他文献
WILLIAM A SCHEFTNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM A SCHEFTNER', 18)}}的其他基金
COLLABORATIVE GENOMIC STUDY OF BIPOLAR DISORDER
双相情感障碍的合作基因组研究
- 批准号:
6392435 - 财政年份:1998
- 资助金额:
$ 28.17万 - 项目类别:
A Collaborative Genomic Study of Bipolar Disorder
双相情感障碍的合作基因组研究
- 批准号:
6861023 - 财政年份:1998
- 资助金额:
$ 28.17万 - 项目类别:
A Collaborative Genomic Study of Bipolar Disorder
双相情感障碍的合作基因组研究
- 批准号:
6991250 - 财政年份:1998
- 资助金额:
$ 28.17万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 28.17万 - 项目类别:
Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 28.17万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 28.17万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 28.17万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 28.17万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 28.17万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 28.17万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 28.17万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 28.17万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 28.17万 - 项目类别: